Acadian Asset Management’s AngioDynamics ANGO Stock Holding History

Acadian Asset Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.32M	Buy	468,670 +278,393	+146%	+$3.02M	0.01%	695
2025 Q4	$2.44M	Buy	190,277 +58,684	+45%	+$724K	﹤0.01%	859
2025 Q3	$1.47M	Buy	+131,593	New	+$1.27M	﹤0.01%	964
2024 Q4	–	Sell	-50,552	Closed	-$393K	–	1617
2024 Q3	$393K	Sell	50,552 -395,964	-89%	-$2.86M	﹤0.01%	1143
2024 Q2	$2.7M	Sell	446,516 -565,670	-56%	-$3.49M	0.01%	680
2024 Q1	$5.94M	Buy	1,012,186 +107,764	+12%	+$640K	0.02%	429
2023 Q4	$7.09M	Buy	904,422 +544,381	+151%	+$3.78M	0.03%	362
2023 Q3	$2.63M	Buy	+360,041	New	+$3M	0.01%	613
2022 Q1	–	Sell	-31,084	Closed	-$854K	–	1632
2021 Q4	$854K	Buy	31,084 +6,197	+25%	+$171K	﹤0.01%	865
2021 Q3	$643K	Buy	+24,887	New	+$665K	﹤0.01%	972
2021 Q1	–	Sell	-55,930	Closed	-$858K	–	2045
2020 Q4	$858K	Sell	55,930 -15,181	-21%	-$193K	﹤0.01%	1038
2020 Q3	$858K	Sell	71,111 -238,252	-77%	-$2.26M	﹤0.01%	958
2020 Q2	$3.15M	Sell	309,363 -149,290	-33%	-$1.54M	0.01%	602
2020 Q1	$4.78M	Buy	458,653 +101,812	+29%	+$1.28M	0.03%	403
2019 Q4	$5.71M	Buy	356,841 +73,320	+26%	+$1.12M	0.03%	413
2019 Q3	$5.22M	Buy	283,521 +100,418	+55%	+$1.96M	0.02%	457
2019 Q2	$3.61M	Sell	183,103 -45,427	-20%	-$925K	0.02%	458
2019 Q1	$5.22M	Sell	228,530 -55,848	-20%	-$1.21M	0.02%	428
2018 Q4	$5.72M	Sell	284,378 -17,690	-6%	-$366K	0.03%	355
2018 Q3	$6.57M	Buy	302,068 +41,279	+16%	+$917K	0.03%	339
2018 Q2	$5.8M	Buy	260,789 +180,824	+226%	+$3.7M	0.03%	371
2018 Q1	$1.38M	Sell	79,965 -28,574	-26%	-$477K	0.01%	671
2017 Q4	$1.8M	Buy	108,539 +27,079	+33%	+$462K	0.01%	577
2017 Q3	$1.39M	Sell	81,460 -147,657	-64%	-$2.48M	0.01%	625
2017 Q2	$3.71M	Sell	229,117 -155,337	-40%	-$2.46M	0.02%	447
2017 Q1	$6.67M	Sell	384,454 -151,841	-28%	-$2.54M	0.03%	360
2016 Q4	$9.05M	Buy	536,295 +402,069	+300%	+$6.71M	0.04%	303
2016 Q3	$2.35M	Buy	134,226 +131,141	+4,251%	+$2.13M	0.01%	509
2016 Q2	$44K	Buy	+3,085	New	+$38.6K	﹤0.01%	1103

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.5M AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $100M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Acadian Asset Management's ANGO Position: Q1 2026 in Review

Acadian Asset Management increased its AngioDynamics (ANGO) stake by 146% in Q1 2026, buying an estimated $3.02M and bringing the position to 468,670 shares worth $5.32M. The position accounts for 0.01% of the portfolio, ranked #695.

Acadian Asset Management first reported a position in ANGO in Q2 2016 and has held it in 29 quarters since. The position peaked at $9.05M in Q4 2016. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

Acadian Asset Management held 468,670 shares of AngioDynamics worth $5.32M as of Q1 2026.
Acadian Asset Management bought 278,393 AngioDynamics shares in Q1 2026, an estimated $3.02M.
AngioDynamics made up 0.01% of Acadian Asset Management's portfolio in Q1 2026, its #695 holding.
Acadian Asset Management first reported a position in AngioDynamics in Q2 2016 and has held it in 29 quarters since.
Acadian Asset Management's AngioDynamics position peaked at $9.05M in Q4 2016.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.